March 13, 2023 – Page 3 – Columbus News Online

Archive

Severe Hypertriglyceridemia Emerging and Marketed Drugs Assessment, (2023 Updates) | Clinical Trials, Latest FDA, EMA, and PMDA Approvals, Treatment Outlook, Competitive Landscape, and Key Companies

Delveinsight Business Research LLP As per DelveInsight’s assessment, about 10+ key pharma and biotech companies are working on 10+ pipeline drugs in the Severe Hypertriglyceridemia (SHTG) therapeutics landscape based on

Type 1 Diabetes Emerging and Marketed Drugs Assessment, (2023 Updates) | Clinical Trials, Latest FDA, EMA, and PMDA Approvals, Treatment Outlook, Competitive Landscape, and Key Companies

Delveinsight Business Research LLP As per DelveInsight’s assessment, globally, about 80+ key pharma and biotech companies are working on 100+ pipeline drugs in the Type 1 Diabetes therapeutics landscape based

Essential Tremor Emerging and Marketed Drugs Assessment, (2023 Updates) | Clinical Trials, Latest FDA, EMA, and PMDA Approvals, Treatment Outlook, Competitive Landscape, and Key Companies

Delveinsight Business Research LLP As per DelveInsight’s assessment, about 7+ key pharma and biotech companies are working on 10+ pipeline drugs in the Essential Tremor therapeutics landscape based on different

Post-Surgical Pain Market to Register Incremental Growth During the Forecast Period (2022-32) – DelveInsight | Key Companies – AcelRx, Trevena, Vivozon, Teikoku Pharma, Nevakar, Oculis, PainReform

Delveinsight Business Research LLP The Post-surgical pain pipeline possesses potential drugs in mid and late-stage developments to be approved in the near future. The major pharma and biotech giants such

Inflammatory Bowel Disease Market to Witness Upsurge in Growth During the Forecast Period (2022-2032), Examine DelveInsight | Key Companies – Janssen, Abbvie, Eli Lilly, Gilead, Galapagos, AstraZeneca

Delveinsight Business Research LLP As per DelveInsight, the Inflammatory Bowel Disease therapeutics market is anticipated to evolve immensely in the coming years owing to the expected launch of investigational drugs

Renal Cell Carcinoma Market is Expected to Expand at a Healthy Growth Rate During the Forecast Period (2022-32), States DelveInsight | Akesobio, Allogene, Betta Pharma, ColImmune, CRISPR Therapeutics

Delveinsight Business Research LLP As per DelveInsight, the Renal Cell Carcinoma therapeutics market is anticipated to evolve immensely in the coming years owing to the expected launch of drugs in

Interstitial Lung Disease Market to Observe Impressive Growth During the Forecast Period (2022-2032), Evaluates DelveInsight | Key Companies – PureTech, Roche, aTyr Pharma, OncoArendi, Daewoong Pharma

Delveinsight Business Research LLP As per DelveInsight, the Interstitial Lung Disease therapeutics market is anticipated to evolve immensely in the coming years owing to the launch of upcoming therapies and

Cushing’s Syndrome Market is Expected to Showcase a Significant Growth During the Forecast Period (2022-2032), Predicts DelveInsight | Key Companies – AstraZeneca, Crinetics, Sparrow Pharma

Delveinsight Business Research LLP As per DelveInsight, the Cushing’s Syndrome Market is anticipated to evolve immensely in the coming years owing to the rise in the number of prevalent population

Cutaneous Squamous Cell Carcinoma Emerging and Marketed Drugs Assessment | Clinical Trials, Latest FDA, EMA, and PMDA Approvals, Treatment Outlook, Competitive Landscape, and Key Companies

Delveinsight Business Research LLP As per DelveInsight’s assessment, about 45+ key pharma and biotech companies are working on 45+ pipeline drugs in the Cutaneous Squamous Cell Carcinoma therapeutics landscape based

Vitiligo Emerging and Marketed Drugs Assessment, (2023 Updates) | Clinical Trials, Latest FDA, EMA, and PMDA Approvals, Treatment Outlook, Competitive Landscape, and Key Companies

Delveinsight Business Research LLP As per DelveInsight’s assessment, about 22+ key pharma and biotech companies are working on 22+ pipeline drugs in the Vitiligo therapeutics landscape based on different Routes

Archive

Loading, Please Wait!